New drug combo keeps kidneys safe in transplant patients
NCT ID NCT06044493
First seen May 10, 2026 · Last updated May 19, 2026 · Updated 2 times
Summary
This study looked at two medicines, MYREPTIC-N and MY-REPT, in 158 adults who had a kidney transplant at least a year ago. The goal was to see if these drugs are safe and effective at preventing organ rejection, graft loss, or death. Participants continued their regular anti-rejection treatment while taking the study drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, 03080, South Korea
Conditions
Explore the condition pages connected to this study.